Vitaspring Biomedical Co Stock Market Value
| VSBC Stock | USD 1.00 0.00 0.00% |
| Symbol | VitaSpring |
VitaSpring Biomedical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to VitaSpring Biomedical's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of VitaSpring Biomedical.
| 07/01/2025 |
| 12/28/2025 |
If you would invest 0.00 in VitaSpring Biomedical on July 1, 2025 and sell it all today you would earn a total of 0.00 from holding VitaSpring Biomedical Co or generate 0.0% return on investment in VitaSpring Biomedical over 180 days. VitaSpring Biomedical is related to or competes with Paradigm Biopharmaceutica, Satellos Bioscience, Kintor Pharmaceutical, Nuo Therapeutics, Imugene, Starpharma Holdings, and Shield Therapeutics. The company was formerly known as Shemn Corp More
VitaSpring Biomedical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure VitaSpring Biomedical's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess VitaSpring Biomedical Co upside and downside potential and time the market with a certain degree of confidence.
VitaSpring Biomedical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for VitaSpring Biomedical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as VitaSpring Biomedical's standard deviation. In reality, there are many statistical measures that can use VitaSpring Biomedical historical prices to predict the future VitaSpring Biomedical's volatility.VitaSpring Biomedical Backtested Returns
We have found three technical indicators for VitaSpring Biomedical Co, which you can use to evaluate the volatility of the company. The entity has a beta of 0.0, which indicates not very significant fluctuations relative to the market. the returns on MARKET and VitaSpring Biomedical are completely uncorrelated.
Auto-correlation | 0.00 |
No correlation between past and present
VitaSpring Biomedical Co has no correlation between past and present. Overlapping area represents the amount of predictability between VitaSpring Biomedical time series from 1st of July 2025 to 29th of September 2025 and 29th of September 2025 to 28th of December 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of VitaSpring Biomedical price movement. The serial correlation of 0.0 indicates that just 0.0% of current VitaSpring Biomedical price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
VitaSpring Biomedical lagged returns against current returns
Autocorrelation, which is VitaSpring Biomedical pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting VitaSpring Biomedical's pink sheet expected returns. We can calculate the autocorrelation of VitaSpring Biomedical returns to help us make a trade decision. For example, suppose you find that VitaSpring Biomedical has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
VitaSpring Biomedical regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If VitaSpring Biomedical pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if VitaSpring Biomedical pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in VitaSpring Biomedical pink sheet over time.
Current vs Lagged Prices |
| Timeline |
VitaSpring Biomedical Lagged Returns
When evaluating VitaSpring Biomedical's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of VitaSpring Biomedical pink sheet have on its future price. VitaSpring Biomedical autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, VitaSpring Biomedical autocorrelation shows the relationship between VitaSpring Biomedical pink sheet current value and its past values and can show if there is a momentum factor associated with investing in VitaSpring Biomedical Co.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in VitaSpring Pink Sheet
VitaSpring Biomedical financial ratios help investors to determine whether VitaSpring Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in VitaSpring with respect to the benefits of owning VitaSpring Biomedical security.